RET-Positive Metastatic NSCLC


 

WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT in Unresectable Locally Advanced NSCLC

63 views
August 29, 2022
0 Comments
Login to view comments. Click here to Login
RET-Positive Metastatic NSCLC